AIR Capital

Feedvax is an innovative company based in Argentina, established in 2018, focused on developing a platform for oral vaccines aimed at improving animal health in aquaculture. Its primary product is an oral vaccine designed to protect farmed tilapia from streptococcosis, a common disease affecting this widely farmed species. Feedvax's platform not only delivers vaccines but also provides a smart feeder that ensures nutritional and health treatments are administered automatically and individually to each animal. The company's solution is environmentally safe, cost-effective, and easy for farmers to use, promoting greater efficiency in animal production while helping to eliminate the need for antibiotics and reducing stress on the fish. By transforming traditional aquaculture practices, Feedvax aims to make a sustainable impact on the industry.

Puna Bio specializes in developing biological products for the agricultural sector. Based in Buenos Aires, Argentina, the company focuses on enhancing crop nutrition using extremophile microorganisms, aiming to improve yields and soil quality sustainably.

Aplife Biotech is an Argentine biotechnology startup founded in 2018, based in Buenos Aires. The company focuses on developing innovative technologies for the high-throughput discovery of novel aptamers, which are synthetic DNA-derived molecules used in biosensors. Aplife Biotech's platform enables the manufacture of large combinatorial libraries of these aptamers in predefined locations, facilitating the mass screening of important biological molecules. This technology addresses global challenges in medical diagnostics by supporting the creation of novel biosensors and diagnostic assays, as well as therapeutic applications.